Quince Therapeutics, Inc. (QNCX)
0.1501
-0.01
(-7.46%)
USD |
NASDAQ |
Feb 20, 16:00
0.1493
0.00 (0.00%)
After-Hours: 20:00
Quince Therapeutics EPS Diluted (Quarterly) : -0.2492 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Masimo Corp. | -1.859 |
| Ocular Therapeutix, Inc. | -0.29 |
| Ernexa Therapeutics, Inc. | -0.1507 |
| Recursion Pharmaceuticals, Inc. | -0.363 |
| RxSight, Inc. | -0.2396 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -13.44M |
| Total Expenses (Quarterly) | 13.44M |
| Enterprise Value | 0.0628M |
| Earnings Yield | -812.1% |
| Normalized Earnings Yield | -677.75 |